首頁 > 市場調查報告書 > 醫療設備

心血管設備

市場調查報告書

商品編碼

1601751

心臟測繪設備市場 - 全球產業規模、佔有率、趨勢、機會和預測，按類型、適應症、最終用途、地區和競爭細分，2019-2029 年

Cardiac Mapping Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Indication, By End-use, By Region & Competition, 2019-2029F

出版日期: 2024年11月30日 | 出版商:

TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2023年全球心臟測繪設備市場價值為21.4億美元，預計2029年將達到31.4億美元，預測期內複合年成長率為10.71%。

市場概況
預測期	2025-2029
2023 年市場規模	21.4億美元
2029 年市場規模	31.4億美元
2024-2029 年複合年成長率	10.71%
成長最快的細分市場	聯絡心臟測繪系統
最大的市場	北美洲

該市場主要是由心血管疾病發病率不斷上升所推動的，心血管疾病仍然是全球發病和死亡的主要原因之一。隨著人口老化，特別是在已開發地區，以及高血壓、糖尿病和肥胖等危險因子的增加，對先進診斷和治療工具的需求不斷增加。因此，從傳統 2D 測繪到先進 3D 系統的心臟測繪技術正在成為電生理學實驗室的重要組成部分，有助於心律不整的診斷和精確引導治療，例如導管消融。

根據心律協會 2023 年 8 月發表的一篇文章，心房顫動 (AFib) 是最常見的心律不整類型，影響全球約 4,000 萬人，其中美國有 600 萬人。 AFib 的廣泛發生凸顯了對先進診斷和治療方案的迫切需求。此外，大約四分之一的 40 歲以上成年人一生中有發生 AFib 的風險。

主要市場促進因素

心血管疾病的盛行率不斷上升

心臟測繪的技術進步與創新

增加心血管護理的醫療支出和投資

主要市場挑戰

高成本和報銷問題

技術複雜性與技能差距

主要市場趨勢

與人工智慧 (AI) 和機器學習 (ML) 整合

遠端監控和遠距醫療整合

細分市場洞察

類型洞察

區域洞察

Market Overview
Forecast Period	2025-2029
Market Size 2023	USD 2.14 Billion
Market Size 2029	USD 3.14 Billion
CAGR 2024-2029	10.71%
Fastest Growing Segment	Contact Cardiac Mapping Systems
Largest Market	North America

The market is primarily driven by the growing incidence of CVDs, which remain one of the leading causes of morbidity and mortality worldwide. With aging populations, particularly in developed regions, and rising risk factors such as hypertension, diabetes, and obesity, the demand for advanced diagnostic and treatment tools is increasing. As a result, cardiac mapping technologies ranging from traditional 2D mapping to advanced 3D systems are becoming essential components of electrophysiology labs, aiding in both diagnosis and the precision-guided treatment of arrhythmias, such as catheter ablation.

According to an article published by the Heart Rhythm Society in August 2023, atrial fibrillation (AFib) is the most prevalent type of cardiac arrhythmia, impacting approximately 40 million people worldwide, including 6 million in the United States. The widespread occurrence of AFib highlights the pressing need for advanced diagnostic and treatment options. Additionally, around 1 in 4 adults over the age of 40 are at risk of developing AFib in their lifetime.

Key Market Drivers

Growing Prevalence of Cardiovascular Diseases

The increasing global burden of cardiovascular diseases (CVDs) is one of the primary drivers of the cardiac mapping devices market. CVDs, which include conditions such as atrial fibrillation, heart attacks, and congestive heart failure, are among the leading causes of death worldwide. According to the World Health Organization (WHO), cardiovascular diseases account for approximately 17.9 million deaths annually, which represents 32% of all global deaths. This alarming rise in heart-related diseases has heightened the demand for innovative medical technologies that can aid in early diagnosis, treatment, and management of such conditions.

Cardiac mapping devices play a crucial role in understanding the electrical activity of the heart, enabling physicians to accurately diagnose and localize arrhythmias, and guide interventions such as catheter ablation. As more patients seek interventions to treat arrhythmias, the need for advanced diagnostic and therapeutic tools like cardiac mapping systems has surged. These devices provide a detailed, real-time 3D map of the heart's electrical system, helping clinicians pinpoint the origin of abnormal electrical impulses responsible for arrhythmias, and thereby improving the precision and success of treatments.

In addition to this, the rising prevalence of lifestyle factors such as obesity, diabetes, and hypertension, which are major contributors to heart disease, further accelerates the demand for cardiac mapping devices. The aging population, particularly in developed countries, also contributes significantly to the increasing incidence of CVDs. Older adults are more prone to conditions such as atrial fibrillation, necessitating more frequent use of advanced diagnostic tools. This trend is expected to continue as populations age globally, further driving the need for sophisticated mapping technologies.

Technological Advancements and Innovations in Cardiac Mapping

The continuous advancements in technology are another key driver propelling the cardiac mapping devices market. Over the past decade, there have been significant innovations in mapping systems, including the development of high-resolution 3D mapping systems, improved imaging technologies, and integration with robotic assistance for enhanced precision in procedures. These technological improvements have expanded the scope of cardiac mapping from traditional 2D to highly sophisticated 3D models of the heart, allowing for better diagnosis and targeted treatment strategies.

One of the major advancements in cardiac mapping technology is the integration of contact and non-contact mapping systems, which allow for a more comprehensive understanding of heart arrhythmias. Contact mapping involves direct interaction with the heart's tissue via a catheter, while non-contact mapping uses sensors outside the body. Non-invasive options are gaining popularity because of their ability to reduce risk, enhance patient comfort, and provide accurate results. The development of high-density, multi-electrode catheters has also improved the resolution of cardiac maps, enabling the detection of arrhythmias at a much finer level of detail.

Another notable advancement is the use of artificial intelligence (AI) and machine learning (ML) in interpreting cardiac mapping data. These technologies can enhance the accuracy of arrhythmia diagnosis, streamline decision-making processes, and reduce the time required for clinicians to interpret complex datasets. AI-driven systems can also help predict the likelihood of future arrhythmic events, providing critical information to guide long-term patient management. The fusion of AI with traditional cardiac mapping devices offers a more personalized approach to treatment, improving both the speed and accuracy of interventions.

Increasing Healthcare Expenditure and Investment in Cardiovascular Care

The rising healthcare expenditure worldwide is another key factor contributing to the growth of the cardiac mapping devices market. Governments and private sectors are increasingly investing in advanced healthcare technologies to meet the growing demand for sophisticated diagnostic and therapeutic tools. This trend is particularly prominent in emerging economies, where healthcare systems are rapidly developing, and there is greater access to high-quality medical care.

In high-income countries, healthcare systems are prioritizing the implementation of cutting-edge medical technologies to enhance treatment outcomes, improve patient care, and reduce the overall healthcare burden. In many cases, cardiac mapping devices are being integrated into routine clinical practice for the management of arrhythmias and other heart conditions. The increasing funding for cardiovascular disease research and development (R&D) is leading to the creation of newer, more effective cardiac mapping systems, which are being rapidly adopted by hospitals and cardiology clinics.

On the other hand, many governments, particularly in Asia-Pacific and Latin America, are investing heavily in the healthcare infrastructure to address the rising incidences of cardiovascular diseases and other chronic health conditions. These regions are experiencing economic growth, and with that comes an increasing focus on improving healthcare delivery. As disposable incomes rise and more people gain access to private healthcare facilities, the demand for advanced medical devices such as cardiac mapping systems is growing.

Key Market Challenges

High Cost and Reimbursement Issues

One of the major challenges in the cardiac mapping devices market is the high cost associated with both the devices themselves and the procedures in which they are used. Cardiac mapping systems, especially advanced 3D mapping technologies, are expensive to develop, manufacture, and maintain. These devices typically require significant investment in research and development (R&D) and can cost hospitals and healthcare facilities hundreds of thousands of dollars to purchase. Furthermore, the associated procedure costs such as those for catheterization, imaging, and physician expertise can significantly add to the financial burden on healthcare providers and patients.

For many healthcare systems, especially in developing or low-resource settings, the cost of implementing advanced cardiac mapping technologies may be prohibitive. Additionally, patients may be unable or unwilling to afford these high-tech procedures, particularly when they are not fully covered by insurance or reimbursement schemes. In several countries, reimbursement policies for specialized diagnostic devices, including cardiac mapping systems, remain complex and inconsistent, which can deter healthcare providers from adopting these technologies.

Despite the growing demand for precision cardiac care, many health insurance companies are reluctant to cover the costs of advanced mapping procedures due to their high price tag, or they may offer only partial reimbursement, further limiting patient access to these technologies. This reimbursement gap can discourage hospitals from investing in cardiac mapping devices, particularly in regions where reimbursement structures are less comprehensive. In turn, the widespread adoption of these devices can be hindered, restricting market growth, especially in economically constrained regions.

Technical Complexity and Skill Gap

Another significant challenge facing the cardiac mapping devices market is the technical complexity of the equipment and the shortage of skilled professionals capable of using them effectively. Cardiac mapping systems, particularly those that involve 3D imaging and real-time data analysis, are highly sophisticated and require significant expertise to operate. Physicians, electrophysiologists, and technicians must undergo extensive training to learn how to use these devices and interpret the data they generate. This need for specialized training can create a bottleneck, especially in regions with limited access to advanced medical education or professional development programs.

The shortage of skilled electrophysiologists and cardiac specialists also presents a challenge, as there is often a high demand for these professionals. While cardiac mapping devices can significantly enhance diagnostic accuracy and treatment success, their effectiveness depends largely on the expertise of the operator. Without sufficient numbers of well-trained specialists to conduct these procedures, the adoption of cardiac mapping technology may be slower, limiting its potential in certain markets. This gap in technical expertise also raises concerns about the quality of care and patient outcomes, as improper use or misinterpretation of mapping data could lead to incorrect diagnoses and suboptimal treatment plans.

Key Market Trends

Integration with Artificial Intelligence (AI) and Machine Learning (ML)

Artificial intelligence (AI) and machine learning (ML) are increasingly becoming integral components of cardiac mapping systems. The incorporation of these technologies is transforming how data from cardiac mapping devices are analyzed and interpreted, allowing for more accurate, efficient, and personalized treatment decisions. AI and ML algorithms can process vast amounts of data in real time, detecting patterns and abnormalities that might be overlooked by human operators.

For example, AI-powered cardiac mapping systems can identify the precise origin of arrhythmias, predict the likelihood of recurrent events, and recommend optimal treatment strategies. These systems can even assist physicians in making more accurate diagnoses, reducing the potential for human error. Moreover, machine learning can help refine and optimize mapping procedures, making them more streamlined and efficient. As AI and ML continue to evolve, the capabilities of cardiac mapping devices will expand, improving their diagnostic and therapeutic potential.

The use of AI also supports the shift toward more personalized medicine. With AI algorithms, clinicians can create tailored treatment plans based on the unique characteristics of each patient's heart and arrhythmia pattern. These developments are not only improving patient outcomes but also making cardiac mapping systems more attractive to healthcare providers, as they can improve the efficiency and precision of procedures, leading to better clinical outcomes and cost savings in the long run.

Remote Monitoring and Telemedicine Integration

The integration of cardiac mapping devices with remote monitoring systems and telemedicine platforms is another emerging trend in the market. Telemedicine has seen exponential growth, particularly in the wake of the COVID-19 pandemic, as patients and healthcare providers have increasingly relied on digital technologies for remote consultations and diagnostics. This trend has extended to the cardiac care space, where telemedicine solutions are being combined with cardiac mapping technology to allow for remote monitoring of patients with arrhythmias and other heart conditions.

With the rise of wearable devices and continuous cardiac monitoring tools, healthcare providers can now track patients' heart activity in real-time, even outside of clinical settings. This remote monitoring can be integrated with cardiac mapping systems, enabling clinicians to perform more accurate diagnoses and make more informed treatment decisions without requiring patients to be physically present in the clinic. In cases of arrhythmias, for example, mapping data can be transmitted remotely to a specialist, who can then analyze the data and provide immediate feedback or treatment recommendations.

Segmental Insights

Type Insights

Based on the type, the contact cardiac mapping systems category held the largest market share during the forecast period. This is due to several key factors, including their high diagnostic accuracy, proven clinical efficacy, and broad range of applications. These systems use catheters with multiple electrodes that directly contact heart tissue, providing detailed, real-time maps of the heart's electrical activity. This precision allows for the accurate localization of arrhythmias, ensuring more effective treatments like catheter ablation. Additionally, contact systems are versatile, applicable to a wide variety of arrhythmias and compatible with advanced therapeutic techniques such as cryoablation and pacing. The integration of contact mapping with ablation technologies has further enhanced their value in electrophysiology, streamlining procedures and improving patient outcomes. The long-standing clinical acceptance of contact mapping, supported by major industry players like Abbott, Biosense Webster, and Medtronic, has solidified its position as the gold standard in arrhythmia treatment. As a result, contact mapping systems remain the preferred choice for electrophysiologists and cardiologists, driving their continued dominance in the global market.

Regional Insights

North America is dominating the Cardiac Mapping Devices Market in 2023, due to a combination of factors, including advanced healthcare infrastructure, high healthcare spending, and a robust regulatory environment. The region is home to state-of-the-art hospitals and medical centers that readily adopt cutting-edge technologies like cardiac mapping systems. This is further supported by high levels of investment in healthcare, with institutions able to afford advanced diagnostic and treatment equipment. Additionally, the strong presence of major industry players such as Biosense Webster, Abbott, and Medtronic ensures the widespread availability of innovative cardiac mapping solutions. The U.S. also benefits from a streamlined regulatory process, with FDA approvals facilitating the rapid introduction of new technologies.

Moreover, the growing aging population and the increasing prevalence of cardiovascular diseases, such as atrial fibrillation, contribute to rising demand for accurate diagnostic tools. Moreover, the growing preference for minimally invasive procedures like catheter ablation drives the need for precise mapping systems, solidifying North America's leadership in the market. With a combination of these factors, North America remains the dominant region in the global cardiac mapping devices market.

Key Market Players

Abbott Laboratories
Medtronic plc
Boston Scientific Corporation
Johnson & Johnson
Koninklijke Philips N.V.
BIOTRONIK SE & Co. KG
MicroPort Scientific Corporation
APN Health, LLC
Acutus Medical, Inc.
BioSig Technologies, Inc.

Report Scope:

In this report, the Global Cardiac Mapping Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cardiac Mapping Devices Market, By Type:

Contact Cardiac Mapping Systems
Non-Contact Cardiac Mapping Systems

Cardiac Mapping Devices Market, By Indication:

Atrial Fibrillation
Atrial Flutter
Others

Cardiac Mapping Devices Market, By End-use:

Hospitals
Diagnostic Centers
Others

Cardiac Mapping Devices Market, By Region:

North America
- United States
- Mexico
- Canada
Europe
- France
- Germany
- United Kingdom
- Italy
- Spain
Asia-Pacific
- China
- India
- South Korea
- Japan
- Australia
South America
- Brazil
- Argentina
- Colombia
Middle East and Africa
- South Africa
- Saudi Arabia
- UAE
- Egypt
- Turkey

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Cardiac Mapping Devices Market.

Available Customizations:

Global Cardiac Mapping Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Cardiac Mapping Devices Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Type (Contact Cardiac Mapping Systems, Non-Contact Cardiac Mapping Systems)
- 5.2.2. By Indication (Atrial Fibrillation, Atrial Flutter, Others)
- 5.2.3. By End-use (Hospitals, Diagnostic Centers, Others)
- 5.2.4. By Region
- 5.2.5. By Company (2023)
5.3. Market Map

6. North America Cardiac Mapping Devices Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Type
- 6.2.2. By Indication
- 6.2.3. By End-use
- 6.2.4. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Cardiac Mapping Devices Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Type
    - 6.3.1.2.2. By Indication
    - 6.3.1.2.3. By End-use
- 6.3.2. Canada Cardiac Mapping Devices Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Type
    - 6.3.2.2.2. By Indication
    - 6.3.2.2.3. By End-use
- 6.3.3. Mexico Cardiac Mapping Devices Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Type
    - 6.3.3.2.2. By Indication
    - 6.3.3.2.3. By End-use

7. Europe Cardiac Mapping Devices Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Type
- 7.2.2. By Indication
- 7.2.3. By End-use
- 7.2.4. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany Cardiac Mapping Devices Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Type
    - 7.3.1.2.2. By Indication
    - 7.3.1.2.3. By End-use
- 7.3.2. United Kingdom Cardiac Mapping Devices Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Type
    - 7.3.2.2.2. By Indication
    - 7.3.2.2.3. By End-use
- 7.3.3. Italy Cardiac Mapping Devices Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecasty
    - 7.3.3.2.1. By Type
    - 7.3.3.2.2. By Indication
    - 7.3.3.2.3. By End-use
- 7.3.4. France Cardiac Mapping Devices Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Type
    - 7.3.4.2.2. By Indication
    - 7.3.4.2.3. By End-use
- 7.3.5. Spain Cardiac Mapping Devices Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Type
    - 7.3.5.2.2. By Indication
    - 7.3.5.2.3. By End-use

8. Asia-Pacific Cardiac Mapping Devices Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Type
- 8.2.2. By Indication
- 8.2.3. By End-use
- 8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
- 8.3.1. China Cardiac Mapping Devices Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Type
    - 8.3.1.2.2. By Indication
    - 8.3.1.2.3. By End-use
- 8.3.2. India Cardiac Mapping Devices Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Type
    - 8.3.2.2.2. By Indication
    - 8.3.2.2.3. By End-use
- 8.3.3. Japan Cardiac Mapping Devices Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Type
    - 8.3.3.2.2. By Indication
    - 8.3.3.2.3. By End-use
- 8.3.4. South Cardiac Mapping Devices Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Type
    - 8.3.4.2.2. By Indication
    - 8.3.4.2.3. By End-use
- 8.3.5. Australia Cardiac Mapping Devices Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Type
    - 8.3.5.2.2. By Indication
    - 8.3.5.2.3. By End-use

9. South America Cardiac Mapping Devices Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Type
- 9.2.2. By Indication
- 9.2.3. By End-use
- 9.2.4. By Country
9.3. South America: Country Analysis
- 9.3.1. Brazil Cardiac Mapping Devices Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Type
    - 9.3.1.2.2. By Indication
    - 9.3.1.2.3. By End-use
- 9.3.2. Argentina Cardiac Mapping Devices Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Type
    - 9.3.2.2.2. By Indication
    - 9.3.2.2.3. By End-use
- 9.3.3. Colombia Cardiac Mapping Devices Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Type
    - 9.3.3.2.2. By Indication
    - 9.3.3.2.3. By End-use

10. Middle East and Africa Cardiac Mapping Devices Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Type
- 10.2.2. By Indication
- 10.2.3. By End-use
- 10.2.4. By Country
10.3. MEA: Country Analysis
- 10.3.1. South Africa Cardiac Mapping Devices Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Type
    - 10.3.1.2.2. By Indication
    - 10.3.1.2.3. By End-use
- 10.3.2. Saudi Arabia Cardiac Mapping Devices Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Type
    - 10.3.2.2.2. By Indication
    - 10.3.2.2.3. By End-use
- 10.3.3. UAE Cardiac Mapping Devices Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Type
    - 10.3.3.2.2. By Indication
    - 10.3.3.2.3. By End-use

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. Porters Five Forces Analysis

13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Products/Services

14. Competitive Landscape

14.1. Medtronic plc
- 14.1.1. Business Overview
- 14.1.2. Company Snapshot
- 14.1.3. Products & Services
- 14.1.4. Financials (As Reported)
- 14.1.5. Recent Developments
- 14.1.6. Key Personnel Details
- 14.1.7. SWOT Analysis
14.2. Abbott Laboratories
14.3. Boston Scientific Corporation
14.4. Johnson & Johnson
14.5. Koninklijke Philips N.V.
14.6. BIOTRONIK SE & Co. KG
14.7. MicroPort Scientific Corporation
14.8. APN Health, LLC
14.9. Acutus Medical, Inc.
14.10. BioSig Technologies, Inc.